Mass spectrometry (MS) is an established analytical technique for the analysis of biomolecules, organic molecules, and synthetic polymers. Because of the high sensitivity and accuracy of MS methods, it has become a powerful tool for testing in various industries. Its value lies in its ability to measure and identify specific species present in complex analytes such as cell cultures, through accurate measurement of the absolute mass of each species.
It is required for MS platforms to be calibrated with a set of known standards to provide accurate and meaningful data. However, there are several shortcomings with existing SoA calibrants, such as short shelf life, uneven mass range, poor resolution at high mass range and time consuming sample preparation. Our SpheriCal® standards are designed from the ground up to exhibit none of these shortcomings, providing ideal calibration across the MS field, allowing greater accuracy for more users and greater confidence in MS data reported worldwide.
The H2020 SME-Instrument feasibility study aimed to facilitate the commercialisation of our patented technology by evaluating and adapting our proposed business plan. A series of actions were carried out to analyse the strengths and weaknesses of our position in the market, and to identify the ideal roadmap to maximize impact in the market with full commercialization.